Read About Our Clinical Validity Study Launch!

Read more

Detect earlier,
treat earlier,
live without
of cancer


Down arrow

Our Mission

A world where cancer screening is precise, conclusive, cost effective, and accessible to all at risk patients

About Us

Our Approach

Our proprietary approach leverages miRNA and AI technology as a new standard of diagnostic screening for at risk cancer patients to enable clearer and more definitive screening, empowering physicians to greatly improve patient outcomes



PREMIR is a blood test that screens for breast cancer in high-risk women

PREMIR test box sample

Publications | News

Preferred Medicine Building Data for Breast Cancer miRNA Screening Test -Aug 5, 2021

Presentation on Machine Learning-based Early Cancer Detection -June 3, 2021

Preferred Medicine establishment by Preferred Networks -Nov. 15, 2018

Stay Informed

Sign up to be the first to hear any updates

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Please try again.
We use cookies to provide you with a greater online experience. By using our sites, you agree to our use of cookies. See our cookie policy.